» Articles » PMID: 10934223

Depletion of CD4(+) T Cells Causes Reactivation of Murine Persistent Tuberculosis Despite Continued Expression of Interferon Gamma and Nitric Oxide Synthase 2

Overview
Journal J Exp Med
Date 2000 Aug 10
PMID 10934223
Citations 134
Authors
Affiliations
Soon will be listed here.
Abstract

Tuberculosis is a major cause of death in much of the world. Current estimates are that one-third of the world's population is infected with Mycobacterium tuberculosis. Most infected persons control the infection but in many cases may not eliminate the organism. Reactivation of this clinically latent infection is responsible for a large proportion of active tuberculosis cases. A major risk factor for reactivation of latent tuberculosis is HIV infection, suggesting a role for the CD4(+) T cell subset in maintaining the latent persistent infection. In this study, we tested the requirement for CD4(+) T cells in preventing reactivation in a murine model of latent tuberculosis. Antibody-mediated depletion of CD4(+) T cells resulted in rapid reactivation of a persistent infection, with dramatically increased bacterial numbers in the organs, increased pathology in the lungs, and decreased survival. Although CD4(+) T cells are believed to be a major source of interferon (IFN)-gamma, expression of the gene for IFN-gamma in the lungs of CD4(+) T cell-depleted mice was similar to that in control mice. In addition, inducible nitric oxide synthase production and activity was unimpaired after CD4(+) T cell depletion, indicating that macrophage activation was present even during CD4(+) T cell deficiency. These data indicate that CD4(+) T cells are necessary to prevent reactivation but may have roles in addition to IFN-gamma production and macrophage activation in controlling a persistent tuberculous infection.

Citing Articles

Heterogeneity in immune cell composition is associated with replication at the granuloma level.

Cooper S, Ackart D, Lanni F, Henao-Tamayo M, Anderson G, Podell B Front Immunol. 2024; 15:1427472.

PMID: 39253081 PMC: 11381408. DOI: 10.3389/fimmu.2024.1427472.


CD4 T cells re-wire granuloma cellularity and regulatory networks to promote immunomodulation following Mtb reinfection.

Bromley J, Ganchua S, Nyquist S, Maiello P, Chao M, Jacob Borish H Immunity. 2024; 57(10):2380-2398.e6.

PMID: 39214090 PMC: 11466276. DOI: 10.1016/j.immuni.2024.08.002.


Reappraising the Role of T Cell-Derived IFN-γ in Restriction of Mycobacterium tuberculosis in the Murine Lung.

Maciag K, Plumlee C, Cohen S, Gern B, Urdahl K J Immunol. 2024; 213(3):339-346.

PMID: 38912839 PMC: 11249196. DOI: 10.4049/jimmunol.2400145.


Re-appraising the role of T-cell derived interferon gamma in restriction of in the murine lung: T-cell derived IFNγ is required to restrict pulmonary Mtb.

Maciag K, Plumlee C, Cohen S, Gern B, Urdahl K bioRxiv. 2024; .

PMID: 38617280 PMC: 11014638. DOI: 10.1101/2024.04.04.588086.


CD4 T cells are homeostatic regulators during reinfection.

Bromley J, Ganchua S, Nyquist S, Maiello P, Chao M, Jacob Borish H bioRxiv. 2024; .

PMID: 38187598 PMC: 10769325. DOI: 10.1101/2023.12.20.572669.


References
1.
Scheuermann R, Racila E . CD19 antigen in leukemia and lymphoma diagnosis and immunotherapy. Leuk Lymphoma. 1995; 18(5-6):385-97. DOI: 10.3109/10428199509059636. View

2.
Ottenhoff T, Kumararatne D, Casanova J . Novel human immunodeficiencies reveal the essential role of type-I cytokines in immunity to intracellular bacteria. Immunol Today. 1998; 19(11):491-4. DOI: 10.1016/s0167-5699(98)01321-8. View

3.
Soong L, Xu J, Grewal I, Kima P, Sun J, Longley Jr B . Disruption of CD40-CD40 ligand interactions results in an enhanced susceptibility to Leishmania amazonensis infection. Immunity. 1996; 4(3):263-73. DOI: 10.1016/s1074-7613(00)80434-3. View

4.
Kamanaka M, Yu P, Yasui T, Yoshida K, Kawabe T, Horii T . Protective role of CD40 in Leishmania major infection at two distinct phases of cell-mediated immunity. Immunity. 1996; 4(3):275-81. DOI: 10.1016/s1074-7613(00)80435-5. View

5.
Campbell K, Ovendale P, Kennedy M, Fanslow W, Reed S, Maliszewski C . CD40 ligand is required for protective cell-mediated immunity to Leishmania major. Immunity. 1996; 4(3):283-9. DOI: 10.1016/s1074-7613(00)80436-7. View